• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ABSORB; BIORESORBABLE SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ABSORB; BIORESORBABLE SCAFFOLD Back to Search Results
Catalog Number UNK ABSORB
Device Problems Product Quality Problem (1506); Material Too Rigid or Stiff (1544)
Patient Problems Angina (1710); Stenosis (2263)
Event Date 06/26/2019
Event Type  Injury  
Manufacturer Narrative
Date of implant, estimated.Exemption number (b)(4) permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The scaffold remains in the patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Na.
 
Event Description
It was reported that approximately 3 years post absorb bioresorbable vascular scaffold (bvs) implantation in the right coronary artery, the patient may have experienced angina.On (b)(6) 2019, optical coherence tomography (oct) was performed, and it was noted that the bvs had not yet been resorbed and restenosis was seen.Angioplasty was performed using a drug eluting balloon to treat the restenosis.No additional information was provided.
 
Manufacturer Narrative
D4: the unique device identifier (udi) is unknown because the part and lot numbers were not provided.The device was not returned for evaluation.A review of the lot history record and complaint history could not be conducted because the part and lot numbers were not provided.The reported patient effects of angina and stenosis are listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use (ifu) as known adverse events associated with the use of a coronary scaffold in native coronary arteries.The investigation determined the reported complaint, additional treatment and hospitalization appear to be related to operational context.A conclusive cause for the reported patient effects and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respects to the design, manufacture, or labeling of the device.Device code 1506 - removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB
Type of Device
BIORESORBABLE SCAFFOLD
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key8857679
MDR Text Key153167782
Report Number2024168-2019-10543
Device Sequence Number1
Product Code PNY
Combination Product (y/n)N
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 02/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/02/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK ABSORB
Was Device Available for Evaluation? No
Date Manufacturer Received02/19/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-